Report cover image

Cell and Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Cell Therapy and Gene Therapy), Service (Process Development, cGMP Manufacturing, Regulatory Services

Publisher The Insight Partners
Published Jan 07, 2026
Length 300 Pages
SKU # TIP20855133

Description

The cell and gene therapy market size is expected to grow from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031; it is projected to register a CAGR of 25.5% during 2025-2031. The increasing prevalence of chronic and genetic diseases, the rapid popularity of outsourcing cell and gene therapy manufacturing, and surging regulatory approvals and commercialization are noteworthy factors contributing to the expansion of the cell and gene therapy market size. Additionally, the development of next-generation gene editing tools is projected to bring new cell and gene therapy market trends in the near future.

AI and automation are making a revolutionary impact in the realm of CGT. This academic field has been using AI for predictive modeling, in association with automated process improvement for planning, to overcome current challenges. CRISPR-GPT at Stanford Medicine, an AI technology capable of automating the planning of experiments related to editing genes, has reduced the “time burden of trial-and-error” phases from months to mere days. Similarly, the Yale School of Medicine’s generative AI model designs “new DNA sequences” to switch genes “on” and “off” for the development of safer “gene therapy vectors” in preclinical studies.

Automation works well with AI as it reduces human involvement in the manufacturing process. In this regard, the Cell Shuttle system by Cellares relies on robotics for completeCAR-T cell manufacturing with higher purity and an increased processing speed of up to 10 times. These developments provide significant benefits. According to BioProcess International, automation can reduce autologous CGT cost by 30-50% through enhanced compliance and flexibility. The synergy between AI and automation fast-tracks CGT, which ensures equal treatment access for those affected by rising chronic diseases, thereby emerging as a significant trend in the cell and gene therapy market.

End User-Based Insights

Based on end user, the cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest cell and gene therapy market share in 2024. The driving forces of growth include increasing expenditures in the healthcare sector and favorable government regulations, which accelerate clinical trials; these offer attractions to MNCs looking for varying genetic backgrounds for the development of personalized medications. The growing number of genetic ailments as well as fewer costs of manufacturing act as stimuli for the domestic manufacturing of medications, thus facilitating a transition from generics to more advanced therapies like CAR-T. Improved regulatory harmonization among the countries, with Japan introducing conditional approval of regenerative therapies since 2014, reduces the risks associated with investment. Key players who have successfully developed CAR-T therapies in Japan include the country's own Astellas Pharma and Takeda Pharmaceutical companies, who have developed CAR-T candidates in Japan through clinical trials in patients with leukemia. Japan has the lead in adopting iPS cell technology through the Fujifilm Cellular Dynamics company. In China, Beigene and Legend Biotech (in collaboration with Johnson & Johnson) have commercialized BCMA-targeted therapies for multiple myeloma, benefiting from massive patient pools and government-backed bioclusters in Shanghai, thereby fueling the cell and gene therapy market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the cell and gene therapy market report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cell and gene therapy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the cell and gene therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the cell and gene therapy market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

300 Pages
1. Executive Summary
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. Cell and Gene Therapy Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 PEST Analysis
2.5 Impact of Artificial Intelligence (AI)
2.6 Cell Therapy or Technology Roadmap
2.7 Sustainability and ESG Trends
2.8 Patent Analysis
2.9 Regulatory Framework
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2024 – By Key Players
3.3 Market Concentration
4. Cell and Gene Therapy Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic and Genetic Diseases
4.1.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surging Regulatory Approvals and Commercialization
4.2 Market Restraints
4.2.1 High Costs of Development and Treatment
4.2.2 Stringent Regulatory Challenges
4.2.3 Shortage Of Skilled Professionals and Infrastructure
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Companies
4.3.2 Supportive Government Initiatives
4.3.3 Rising Investments in Research & Development and Clinical Trials
4.4 Future Trends
4.4.1 Integration of AI and Automation
4.4.2 Development of Next-Generation Gene Editing Tools
4.4.3 Rise of Allogeneic and Off-The-Shelf Therapies
4.5 Impact of Drivers and Restraints
5. Cell and Gene Therapy Market – Global Market Analysis
5.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
5.2 Cell and Gene Therapy Market Forecast and Analysis
6. Cell and Gene Therapy Market Revenue Analysis –Type
6.1 Cell and Gene Therapy Market Forecasts and Analysis by Type
6.1.1 Cell Therapy
6.1.1.1 Overview
6.1.1.2 Cell Therapy: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
6.1.2 Gene Therapy
6.1.2.1 Overview
6.1.2.2 Gene Therapy: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7. Cell and Gene Therapy Market Revenue Analysis –Service
7.1 Cell and Gene Therapy Market Forecasts and Analysis by Service
7.1.1 Process Development
7.1.1.1 Overview
7.1.1.2 Process Development: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7.1.2 cGMP Manufacturing
7.1.2.1 Overview
7.1.2.2 cGMP Manufacturing: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7.1.3 Regulatory Services
7.1.3.1 Overview
7.1.3.2 Regulatory Services: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7.1.4 Bioassay Services
7.1.4.1 Overview
7.1.4.2 Bioassay Services: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
8. Cell and Gene Therapy Market Revenue Analysis – Scale
8.1 Cell and Gene Therapy Market Forecasts and Analysis by Scale
8.1.1 Pre-commercial/R and D Manufacturing
8.1.1.1 Overview
8.1.1.2 Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
8.1.2 Commercial Scale Manufacturing
8.1.2.1 Overview
8.1.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
9. Cell and Gene Therapy Market Revenue Analysis –Service Providers
9.1 Cell and Gene Therapy Market Forecasts and Analysis by Service Providers
9.1.1 CDMOs
9.1.1.1 Overview
9.1.1.2 CDMOs: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
9.1.2 CMOs
9.1.2.1 Overview
9.1.2.2 CMOs: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10. Cell and Gene Therapy Market Revenue Analysis – Transfection Reagents
10.1 Cell and Gene Therapy Market Forecasts and Analysis by Transfection Reagents
10.1.1 Polymer-based Transfection Reagents
10.1.1.1 Overview
10.1.1.2 Polymer-based Transfection Reagents: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10.1.2 Lipid-based Transfection Reagents
10.1.2.1 Overview
10.1.2.2 Lipid-based Transfection Reagents: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10.1.3 Viral Transduction Enhancers
10.1.3.1 Overview
10.1.3.2 Viral Transduction Enhancers: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10.1.4 Other Transfection Reagents
10.1.4.1 Overview
10.1.4.2 Other Transfection Reagents: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
11. Cell and Gene Therapy Market Revenue Analysis – By End User
11.1 Cell and Gene Therapy Market Forecasts and Analysis by End User
11.1.1 Contract Research Organizations
11.1.1.1 Overview
11.1.1.2 Contract Research Organizations: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
11.1.2 Pharmaceutical and Biopharmaceutical Companies
11.1.2.1 Overview
11.1.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
11.1. Academic and Research Institutes
11.1.3.1 Overview
11.1.3.2 Academic and Research Institutes: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
12. Cell and Gene Therapy Market – Geographical Analysis
12.1 North America
12.1.1 North America Cell and Gene Therapy Market Overview
12.1.2 North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.3 North America: Cell and Gene Therapy Market– By Segmentation
12.1.3.1 Type
12.1.3.2 Cell Therapy For Type
12.1.3.3 Gene Therapy For Type
12.1.3.4 Service
12.1.3.5 Scale
12.1.3.6 Service Providers
12.1.3.7 Transfection Reagents
12.1.3.8 End User
12.1.4 North America: Cell and Gene Therapy Market Breakdown by Countries
12.1.4.1 United States Market
12.1.4.1.1 United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.1.2 United States: Cell and Gene Therapy Market– By Segmentation
12.1.4.1.2.1 Type
12.1.4.1.2.2 Cell Therapy For Type
12.1.4.1.2.3 Gene Therapy For Type
12.1.4.1.2.4 Service
12.1.4.1.2.5 Scale
12.1.4.1.2.6 Service Providers
12.1.4.1.2.7 Transfection Reagents
12.1.4.1.2.8 End User
12.1.4.2 Canada Market
12.1.4.2.1 Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.2.2 Canada: Cell and Gene Therapy Market– By Segmentation
12.1.4.2.2.1 Type
12.1.4.2.2.2 Cell Therapy For Type
12.1.4.2.2.3 Gene Therapy For Type
12.1.4.2.2.4 Service
12.1.4.2.2.5 Scale
12.1.4.2.2.6 Service Providers
12.1.4.2.2.7 Transfection Reagents
12.1.4.2.2.8 End User
12.1.4.3 Mexico Market
12.1.4.3.1 Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.3.2 Mexico: Cell and Gene Therapy Market– By Segmentation
12.1.4.3.2.1 Type
12.1.4.3.2.2 Cell Therapy For Type
12.1.4.3.2.3 Gene Therapy For Type
12.1.4.3.2.4 Service
12.1.4.3.2.5 Scale
12.1.4.3.2.6 Service Providers
12.1.4.3.2.7 Transfection Reagents
12.1.4.3.2.8 End User
12.2 Europe
12.2.1 Europe Cell and Gene Therapy Market Overview
12.2.2 Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.3 Europe: Cell and Gene Therapy Market– By Segmentation
12.2.3.1 Type
12.2.3.2 Cell Therapy For Type
12.2.3.3 Gene Therapy For Type
12.2.3.4 Service
12.2.3.5 Scale
12.2.3.6 Service Providers
12.2.3.7 Transfection Reagents
12.2.3.8 End User
12.2.4 Europe: Cell and Gene Therapy Market Breakdown by Countries
12.2.4.1 United Kingdom Market
12.2.4.1.1 United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.1.2 United Kingdom: Cell and Gene Therapy Market– By Segmentation
12.2.4.1.2.1 Type
12.2.4.1.2.2 Cell Therapy For Type
12.2.4.1.2.3 Gene Therapy For Type
12.2.4.1.2.4 Service
12.2.4.1.2.5 Scale
12.2.4.1.2.6 Service Providers
12.2.4.1.2.7 Transfection Reagents
12.2.4.1.2.8 End User
12.2.4.2 Germany Market
12.2.4.2.1 Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.2.2 Germany: Cell and Gene Therapy Market– By Segmentation
12.2.4.2.2.1 Type
12.2.4.2.2.2 Cell Therapy For Type
12.2.4.2.2.3 Gene Therapy For Type
12.2.4.2.2.4 Service
12.2.4.2.2.5 Scale
12.2.4.2.2.6 Service Providers
12.2.4.2.2.7 Transfection Reagents
12.2.4.2.2.8 End User
12.2.4.3 France Market
12.2.4.3.1 France: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.3.2 France: Cell and Gene Therapy Market– By Segmentation
12.2.4.3.2.1 Type
12.2.4.3.2.2 Cell Therapy For Type
12.2.4.3.2.3 Gene Therapy For Type
12.2.4.3.2.4 Service
12.2.4.3.2.5 Scale
12.2.4.3.2.6 Service Providers
12.2.4.3.2.7 Transfection Reagents
12.2.4.3.2.8 End User
12.2.4.4 Italy Market
12.2.4.4.1 Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.4.2 Italy: Cell and Gene Therapy Market– By Segmentation
12.2.4.4.2.1 Type
12.2.4.4.2.2 Cell Therapy For Type
12.2.4.4.2.3 Gene Therapy For Type
12.2.4.4.2.4 Service
12.2.4.4.2.5 Scale
12.2.4.4.2.6 Service Providers
12.2.4.4.2.7 Transfection Reagents
12.2.4.4.2.8 End User
12.2.4.5 Spain Market
12.2.4.5.1 Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.5.2 Spain: Cell and Gene Therapy Market– By Segmentation
12.2.4.5.2.1 Type
12.2.4.5.2.2 Cell Therapy For Type
12.2.4.5.2.3 Gene Therapy For Type
12.2.4.5.2.4 Service
12.2.4.5.2.5 Scale
12.2.4.5.2.6 Service Providers
12.2.4.5.2.7 Transfection Reagents
12.2.4.5.2.8 End User
12.2.4.6 Rest of Europe Market
12.2.4.6.1 Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.6.2 Rest of Europe: Cell and Gene Therapy Market– By Segmentation
12.2.4.6.2.1 Type
12.2.4.6.2.2 Cell Therapy For Type
12.2.4.6.2.3 Gene Therapy For Type
12.2.4.6.2.4 Service
12.2.4.6.2.5 Scale
12.2.4.6.2.6 Service Providers
12.2.4.6.2.7 Transfection Reagents
12.2.4.6.2.8 End User
12.3 Asia Pacific
12.3.1 Asia Pacific Cell and Gene Therapy Market Overview
12.3.2 Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.3 Asia Pacific: Cell and Gene Therapy Market– By Segmentation
12.3.3.1 Type
12.3.3.2 Cell Therapy For Type
12.3.3.3 Gene Therapy For Type
12.3.3.4 Service
12.3.3.5 Scale
12.3.3.6 Service Providers
12.3.3.7 Transfection Reagents
12.3.3.8 End User
12.3.4 Asia Pacific: Cell and Gene Therapy Market Breakdown by Countries
12.3.4.1 China Market
12.3.4.1.1 China: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.1.2 China: Cell and Gene Therapy Market– By Segmentation
12.3.4.1.2.1 Type
12.3.4.1.2.2 Cell Therapy For Type
12.3.4.1.2.3 Gene Therapy For Type
12.3.4.1.2.4 Service
12.3.4.1.2.5 Scale
12.3.4.1.2.6 Service Providers
12.3.4.1.2.7 Transfection Reagents
12.3.4.1.2.8 End User
12.3.4.2 Japan Market
12.3.4.2.1 Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.2.2 Japan: Cell and Gene Therapy Market– By Segmentation
12.3.4.2.2.1 Type
12.3.4.2.2.2 Cell Therapy For Type
12.3.4.2.2.3 Gene Therapy For Type
12.3.4.2.2.4 Service
12.3.4.2.2.5 Scale
12.3.4.2.2.6 Service Providers
12.3.4.2.2.7 Transfection Reagents
12.3.4.2.2.8 End User
12.3.4.3 India Market
12.3.4.3.1 India: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.3.2 India: Cell and Gene Therapy Market– By Segmentation
12.3.4.3.2.1 Type
12.3.4.3.2.2 Cell Therapy For Type
12.3.4.3.2.3 Gene Therapy For Type
12.3.4.3.2.4 Service
12.3.4.3.2.5 Scale
12.3.4.3.2.6 Service Providers
12.3.4.3.2.7 Transfection Reagents
12.3.4.3.2.8 End User
12.3.4.4 Australia Market
12.3.4.4.1 Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.4.2 Australia: Cell and Gene Therapy Market– By Segmentation
12.3.4.4.2.1 Type
12.3.4.4.2.2 Cell Therapy For Type
12.3.4.4.2.3 Gene Therapy For Type
12.3.4.4.2.4 Service
12.3.4.4.2.5 Scale
12.3.4.4.2.6 Service Providers
12.3.4.4.2.7 Transfection Reagents
12.3.4.4.2.8 End User
12.3.4.5 South Korea Market
12.3.4.5.1 South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.5.2 South Korea: Cell and Gene Therapy Market– By Segmentation
12.3.4.5.2.1 Type
12.3.4.5.2.2 Cell Therapy For Type
12.3.4.5.2.3 Gene Therapy For Type
12.3.4.5.2.4 Service
12.3.4.5.2.5 Scale
12.3.4.5.2.6 Service Providers
12.3.4.5.2.7 Transfection Reagents
12.3.4.5.2.8 End User
12.3.4.6 Rest of APAC Market
12.3.4.6.1 Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.6.2 Rest of APAC: Cell and Gene Therapy Market– By Segmentation
12.3.4.6.2.1 Type
12.3.4.6.2.2 Cell Therapy For Type
12.3.4.6.2.3 Gene Therapy For Type
12.3.4.6.2.4 Service
12.3.4.6.2.5 Scale
12.3.4.6.2.6 Service Providers
12.3.4.6.2.7 Transfection Reagents
12.3.4.6.2.8 End User
12.4 Middle East and Africa
12.4.1 Middle East and Africa Cell and Gene Therapy Market Overview
12.4.2 Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.3 Middle East and Africa: Cell and Gene Therapy Market– By Segmentation
12.4.3.1 Type
12.4.3.2 Cell Therapy For Type
12.4.3.3 Gene Therapy For Type
12.4.3.4 Service
12.4.3.5 Scale
12.4.3.6 Service Providers
12.4.3.7 Transfection Reagents
12.4.3.8 End User
12.4.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown by Countries
12.4.4.1 Saudi Arabia Market
12.4.4.1.1 Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.1.2 Saudi Arabia: Cell and Gene Therapy Market– By Segmentation
12.4.4.1.2.1 Type
12.4.4.1.2.2 Cell Therapy For Type
12.4.4.1.2.3 Gene Therapy For Type
12.4.4.1.2.4 Service
12.4.4.1.2.5 Scale
12.4.4.1.2.6 Service Providers
12.4.4.1.2.7 Transfection Reagents
12.4.4.1.2.8 End User
12.4.4.2 South Africa Market
12.4.4.2.1 South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.2.2 South Africa: Cell and Gene Therapy Market– By Segmentation
12.4.4.2.2.1 Type
12.4.4.2.2.2 Cell Therapy For Type
12.4.4.2.2.3 Gene Therapy For Type
12.4.4.2.2.4 Service
12.4.4.2.2.5 Scale
12.4.4.2.2.6 Service Providers
12.4.4.2.2.7 Transfection Reagents
12.4.4.2.2.8 End User
12.4.4.3 United Arab Emirates Market
12.4.4.3.1 United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.3.2 United Arab Emirates: Cell and Gene Therapy Market– By Segmentation
12.4.4.3.2.1 Type
12.4.4.3.2.2 Cell Therapy For Type
12.4.4.3.2.3 Gene Therapy For Type
12.4.4.3.2.4 Service
12.4.4.3.2.5 Scale
12.4.4.3.2.6 Service Providers
12.4.4.3.2.7 Transfection Reagents
12.4.4.3.2.8 End User
12.4.4.4 Rest of Middle East and Africa Market
12.4.4.4.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.4.2 Rest of Middle East and Africa: Cell and Gene Therapy Market– By Segmentation
12.4.4.4.2.1 Type
12.4.4.4.2.2 Cell Therapy For Type
12.4.4.4.2.3 Gene Therapy For Type
12.4.4.4.2.4 Service
12.4.4.4.2.5 Scale
12.4.4.4.2.6 Service Providers
12.4.4.4.2.7 Transfection Reagents
12.4.4.4.2.8 End User
12.5 South and Central America
12.5.1 South and Central America Cell and Gene Therapy Market Overview
12.5.2 South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.3 South and Central America: Cell and Gene Therapy Market– By Segmentation
12.5.3.1 Type
12.5.3.2 Cell Therapy For Type
12.5.3.3 Gene Therapy For Type
12.5.3.4 Service
12.5.3.5 Scale
12.5.3.6 Service Providers
12.5.3.7 Transfection Reagents
12.5.3.8 End User
12.5.4 South and Central America: Cell and Gene Therapy Market Breakdown by Countries
12.5.4.1 Brazil Market
12.5.4.1.1 Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.4.1.2 Brazil: Cell and Gene Therapy Market– By Segmentation
12.5.4.1.2.1 Type
12.5.4.1.2.2 Cell Therapy For Type
12.5.4.1.2.3 Gene Therapy For Type
12.5.4.1.2.4 Service
12.5.4.1.2.5 Scale
12.5.4.1.2.6 Service Providers
12.5.4.1.2.7 Transfection Reagents
12.5.4.1.2.8 End User
12.5.4.2 Argentina Market
12.5.4.2.1 Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.4.2.2 Argentina: Cell and Gene Therapy Market– By Segmentation
12.5.4.2.2.1 Type
12.5.4.2.2.2 Cell Therapy For Type
12.5.4.2.2.3 Gene Therapy For Type
12.5.4.2.2.4 Service
12.5.4.2.2.5 Scale
12.5.4.2.2.6 Service Providers
12.5.4.2.2.7 Transfection Reagents
12.5.4.2.2.8 End User
12.5.4.3 Rest of South and Central America Market
12.5.4.3.1 Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.4.3.2 Rest of South and Central America: Cell and Gene Therapy Market– By Segmentation
12.5.4.3.2.1 Type
12.5.4.3.2.2 Cell Therapy For Type
12.5.4.3.2.3 Gene Therapy For Type
12.5.4.3.2.4 Service
12.5.4.3.2.5 Scale
12.5.4.3.2.6 Service Providers
12.5.4.3.2.7 Transfection Reagents
12.5.4.3.2.8 End User
13. Cell and Gene Therapy Market Industry Landscape
14. Cell and Gene Therapy Market – Key Company Profiles
14.1 CRISPR Therapeutics
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Cell Therapys and Gene Therapy
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Horizon Discovery Group plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Cell Therapys and Gene Therapy
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Cell Therapys and Gene Therapy
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Cell Therapys and Gene Therapy
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Integrated DNA Technologies Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Cell Therapys and Gene Therapy
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 QIAGEN NV
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Cell Therapys and Gene Therapy
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Takara Bio Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Cell Therapys and Gene Therapy
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Synthego Holdings LLC
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Cell Therapys and Gene Therapy
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GenScript Biotech Corporation
14.9.1 Key Facts
14.12.2 Business Description
14.12.3 Cell Therapys and Gene Therapy
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.9.6 Key Developments
14.10 Editas Medicine Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Cell Therapys and Gene Therapy
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary
15.2 Research Methodology and Approach
15.2.1 Secondary Research
15.2.2 Primary Research
15.2.3 Market Estimation Approach
15.2.3.1 Supply Side Analysis
15.2.3.2 Demand Side Analysis
15.2.4 Research Assumptions and Limitations
15.2.5 Currency Conversion
15.3 About The Insight Partners
15.4 Market Intelligence Cloud
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. List of Service Providers
Table 3. List of Potential Customers
Table 4. List of Patents and Description
Table 5. List of Regulatory Bodies and Organizations
Table 6. Ease of Doing Business: Key Country Rankings
Table 7. Market Share Analysis, 2024 – By Key Players
Table 8. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million)
Table 6. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million)
Table 7. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Type
Table 8. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Type
Table 9. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 10. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 11. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 12. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 13. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 14. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 15. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 16. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 17. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 18. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 19. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 20. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 21. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 22. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 23. North America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 24. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 25. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 26. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 27. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 28. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 29. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 30. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 31. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 32. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 33. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 34. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 35. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 36. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 37. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 38. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 39. North America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 40. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 41. United States: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 42. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 43. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 44. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 45. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 46. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 47. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 48. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 49. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 50. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 51. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 52. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 53. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 54. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 55. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 56. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 57. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 58. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 59. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 60. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 61. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 62. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 63. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 64. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 65. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 66. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 67. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 68. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 69. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 70. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 71. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 72. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 73. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 74. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 75. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 76. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 77. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 78. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 79. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 80. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 81. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 82. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 83. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 84. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 85. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 86. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 87. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us